Published in Surgery on December 01, 2000
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Gut (2005) 3.32
Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors. Gastroenterology (2008) 3.04
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs). Gut (2011) 2.14
Neuroendocrine tumors of the pancreas. Surg Endosc (2003) 1.53
Occult sporadic insulinoma: localization and surgical strategy. World J Gastroenterol (2008) 1.18
Insulinoma and anaesthetic implications. Indian J Anaesth (2012) 1.03
Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors. Medicine (Baltimore) (2013) 1.00
Selective intra-arterial calcium stimulation with hepatic venous sampling for preoperative localization of insulinomas. Korean J Radiol (2003) 0.92
Rapid intraoperative insulin assay: a novel method to differentiate insulinoma from nesidioblastosis in the pediatric patient. Ann Surg Innov Res (2007) 0.79
Imaging in multiple endocrine neoplasia type 1: recent studies show enhanced sensitivities but increased controversies. Int J Endocr Oncol (2016) 0.79
Diagnosis and localization of insulinoma after negative laparotomy by hyperinsulinemic, hypoglycemic clamp and intra-arterial calcium stimulation. Rev Diabet Stud (2004) 0.77
Octreotide-treated diabetes accompanied by endogenous hyperinsulinemic hypoglycemia and protein-losing gastroenteropathy. Case Rep Med (2011) 0.75
Intra-arterial calcium stimulation test with hepatic venous sampling for preoperative diagnosis of a large insulinoma in an obese young man. Singapore Med J (2014) 0.75
Efficacy of laparoscopic ultrasonography in laparoscopic resection of insulinoma. Endosc Ultrasound (2017) 0.75
Multifocal lesions with pancreatic atrophy in IgG4-related autoimmune pancreatitis: report of a case. Surg Today (2013) 0.75
Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol (2001) 6.83
Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg (2000) 4.44
Endoscopic biliary drainage for severe acute cholangitis. N Engl J Med (1992) 4.29
Prospective randomized study of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Ann Surg (1998) 3.43
Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg (2001) 3.25
Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer (2000) 3.23
Raised serum levels of tumour necrosis factor in parasitic infections. Lancet (1986) 3.23
Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg (1999) 3.05
Hepatic resection for hepatocellular carcinoma. An audit of 343 patients. Ann Surg (1995) 3.04
Anterior approach for difficult major right hepatectomy. World J Surg (1996) 2.94
Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study. Ann Surg (1997) 2.83
Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors. J Biol Chem (1997) 2.73
Serum leptin and vascular risk factors in obstructive sleep apnea. Chest (2000) 2.53
Hepatocellular carcinoma in the elderly: results of surgical and nonsurgical management. Am J Gastroenterol (1999) 2.47
Adult-to-adult living donor liver transplantation using extended right lobe grafts. Ann Surg (1997) 2.44
Preoperative endoscopic drainage for malignant obstructive jaundice. Br J Surg (1994) 2.22
Low-molecular-weight heparin for the treatment of acute ischemic stroke. N Engl J Med (1995) 2.17
beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance. Cancer (2001) 2.17
Clinical implications of circulating angiogenic factors in cancer patients. J Clin Oncol (2001) 2.15
Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma. Br J Surg (2003) 2.10
The clinical significance of routine histopathologic study of the resected appendix and safety of appendiceal inversion. Surg Gynecol Obstet (1986) 2.02
Significance of resection margin in hepatectomy for hepatocellular carcinoma: A critical reappraisal. Ann Surg (2000) 2.01
Pancreatic solid-cystic-papillary tumor: clinicopathologic features in eight patients from Hong Kong and review of the literature. World J Surg (1999) 1.98
Management of spontaneous rupture of hepatocellular carcinoma: single-center experience. J Clin Oncol (2001) 1.93
Early versus delayed laparoscopic cholecystectomy for treatment of acute cholecystitis. Ann Surg (1996) 1.92
The bacteriology and septic complication of patients with appendicitis. Ann Surg (1984) 1.89
Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg (1997) 1.86
Anterior approach for major right hepatic resection for large hepatocellular carcinoma. Ann Surg (2000) 1.83
Identification and characterization of a novel human aldose reductase-like gene. J Biol Chem (1998) 1.82
Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis. J Infect Dis (1997) 1.76
Treatment of advanced hepatocellular carcinoma with tamoxifen and the correlation with expression of hormone receptors: a prospective randomized study. Am J Gastroenterol (2000) 1.73
Construction and testing of mouse--human heteromyelomas for human monoclonal antibody production. Proc Natl Acad Sci U S A (1983) 1.70
Spontaneous rupture of hepatocellular carcinoma. Br J Surg (1996) 1.68
Peptide and small molecule microarray for high throughput cell adhesion and functional assays. Bioconjug Chem (2001) 1.65
Biliary complications after hepatic resection: risk factors, management, and outcome. Arch Surg (1998) 1.63
Bleeding peptic ulcer: a prospective evaluation of risk factors for rebleeding and mortality. World J Surg (1990) 1.63
Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence. J Surg Oncol (2000) 1.62
Human respiratory tract secretion. Mucous glycoproteins of nonpurulent tracheobronchial secretions, and sputum of patients with bronchitis and cystic fibrosis. Arch Biochem Biophys (1976) 1.60
Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Br J Surg (2007) 1.56
Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma: a randomized controlled trial. Arch Surg (1998) 1.54
Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study. Ann Surg (2001) 1.52
Management outcome and the role of manipulation in slipped capital femoral epiphysis. J Orthop Surg (Hong Kong) (2007) 1.49
MRI appearance of synovial chondromatosis in the temporomandibular joint. Clin Radiol (2001) 1.48
Case report: pseudoarthrosis complicating ankylosing spondylitis--appearances on magnetic imaging. Clin Radiol (1993) 1.47
Necrotizing enterocolitis in neonates with symptomatic congenital heart disease. J Pediatr (1988) 1.46
The effect of somatostatin versus corticosteroid in the treatment of Graves' ophthalmopathy. Thyroid (1996) 1.45
Prolactin profile in a cohort of Chinese systemic lupus erythematosus patients. Br J Rheumatol (1997) 1.43
A case-controlled MRI/MRA study of neurovascular contact in hemifacial spasm. Neurology (1999) 1.43
Diagnostic value of prolonged latencies in the vestibular evoked myogenic potential. Arch Otolaryngol Head Neck Surg (2001) 1.43
Prolonged survival in selected patients following surgical resection for pulmonary metastasis from hepatocellular carcinoma. Br J Surg (1998) 1.42
Desmopressin does not decrease blood loss and transfusion requirements in patients undergoing hepatectomy. Can J Anaesth (2003) 1.42
Resection of phaeochromocytoma extending into the right atrium in a patient with multiple endocrine neoplasia type 2A. Hong Kong Med J (2005) 1.42
Clinicopathologic features of long-term survivors and disease-free survivors after resection of hepatocellular carcinoma: a study of a prospective cohort. J Clin Oncol (2001) 1.41
AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma. Oncogene (2010) 1.40
Hypertrichosis due to porphyria cutanea tarda associated with blastic transformation of myelofibrosis. Br J Dermatol (1999) 1.40
Effect of fluorescently labeling protein probes on kinetics of protein-ligand reactions. Langmuir (2008) 1.40
Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma. Am J Clin Pathol (2001) 1.39
Minimum graft size for successful living donor liver transplantation. Transplantation (1999) 1.39
Pancreatic pleural effusion: an indication for emergency distal pancreatectomy and Roux-en-Y pancreatico-jejunostomy. J Pediatr Surg (1994) 1.38
Effect of lysine on hemolysis-induced kidney damage. J Lab Clin Med (1992) 1.38
New methods of measuring vertebral rotation from computed tomographic scans. An intraobserver and interobserver study on girls with scoliosis. Spine (Phila Pa 1976) (1993) 1.37
Selective phosphorylation of a nuclear envelope polypeptide by an endogenous protein kinase. Biochemistry (1979) 1.37
Non-operative diagnosis of renal sinus lipomatosis simulating tumour of the renal pelvis. Br J Urol (1988) 1.37
Early decision for conversion of laparoscopic to open cholecystectomy for treatment of acute cholecystitis. Am J Surg (1997) 1.36
Resection for extrahepatic recurrence of hepatocellular carcinoma. Br J Surg (1994) 1.34
Prognostic significance of pathologic features of hepatocellular carcinoma. A multivariate analysis of 278 patients. Cancer (1995) 1.33
Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trials. Curr Cancer Drug Targets (2011) 1.33
Electrophoretic analysis of three major nuclear envelope polypeptides. Topological relationship and sequence homology. J Biol Chem (1979) 1.32
Profunda femoris artery pseudoaneurysm presenting with triad of thigh swelling, bleeding and anaemia. Ann Acad Med Singapore (2004) 1.32
A novel high-throughput scanning microscope for label-free detection of protein and small-molecule chemical microarrays. Rev Sci Instrum (2008) 1.32
Long-term results of resection for large hepatocellular carcinoma: a multivariate analysis of clinicopathological features. Hepatology (1990) 1.31
Spontaneous rupture of hepatocellular carcinoma and vascular injury. Arch Surg (2001) 1.30
Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: connecting xenobiotics with primary biliary cirrhosis. J Immunol (2001) 1.28
Factors affecting conversion of laparoscopic cholecystectomy to open surgery. Arch Surg (1996) 1.28
Pyogenic liver abscess. An audit of experience over the past decade. Arch Surg (1996) 1.27
Somatostatin in the treatment of acute pancreatitis: a prospective randomised controlled trial. Gut (1989) 1.26
Biochemistry of airway mucus secretions. Fed Proc (1980) 1.25
Tumor encapsulation in hepatocellular carcinoma. A pathologic study of 189 cases. Cancer (1992) 1.25
Long term prognosis after hepatectomy for hepatocellular carcinoma: a survival analysis of 204 consecutive patients. Cancer (1998) 1.24
Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis. J Clin Oncol (2000) 1.24
Imaging of peripheral PNET: common and uncommon locations. Clin Radiol (2002) 1.24
Prognostic significance of proliferating cell nuclear antigen expression in hepatocellular carcinoma. Cancer (1994) 1.23
Biliary complications during liver resection. World J Surg (2001) 1.23
Major hepatectomy for hepatocellular carcinoma in patients with an unsatisfactory indocyanine green clearance test. Br J Surg (1999) 1.22
Ruptured hepatocellular carcinoma as a complication of transarterial oily chemoembolization. Br J Surg (1998) 1.22
Both ATP sites of human P-glycoprotein are essential but not symmetric. Biochemistry (1999) 1.22
Acute torsion of the gall bladder in the aged: a re-emphasis on clinical diagnosis. Aust N Z J Surg (1982) 1.21
Pragmatic reasoning schemas. Cogn Psychol (1985) 1.21
Endoscopic retrograde cholangiopancreatography and endoscopic endoprosthesis insertion in patients with Klatskin tumors. Arch Surg (1998) 1.21
Laparoscopy and laparoscopic ultrasonography avoid exploratory laparotomy in patients with hepatocellular carcinoma. Ann Surg (1998) 1.20
The posterior "nutcracker": hematuria secondary to retroaortic left renal vein. Urology (1986) 1.20
Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial. Gastrointest Endosc (1999) 1.19
Enhanced host cell reactivation of damaged plasmid DNA in HeLa cells resistant to cis-diamminedichloroplatinum(II). Cancer Res (1991) 1.16
Glycomics analysis of serum: a potential new biomarker for ovarian cancer? Int J Gynecol Cancer (2007) 1.16
Liver transplantation in rats using small-for-size grafts: a study of hemodynamic and morphological changes. Arch Surg (2001) 1.15
Correlation of serum basic fibroblast growth factor levels with clinicopathologic features and postoperative recurrence in hepatocellular carcinoma. Am J Surg (2001) 1.15